pembrolizumab
merck
['renal,(-adrenal)', 'keynote 564', 'pembro', '4512']
#asco22 poster#4512 updated data on adjuvant pembrolizumab in surgically respected renal cell carcinoma, extended efficacy analysis from keynote 564 by 
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/qcdl195o3E